Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA.

Robert C, Gérard E, Lanoy E, Quéreux G, Bernard P, Viguier M, Grange F, Meyer N, Dinulescu M, Legoupil D, Neidhardt EM, Saiag P, Trabelsi S, Célérier P, Nardin C, Maubec E, Duval-Modeste AB, Hainaut E, Darras S, Maillard H, Guegan S, Arnault JP, Stoebner PE, LE Corre Y, Peuvrel L, Bonniaud B, Herrscher H, Granel-Brocard F, Vataire AL, Tabellion A, Lebbé C, Mortier L.

Open source

DOI: 10.1016/j.ejca.2026.116596
Published: 2026-03-05
Container: Eur J Cancer
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ejca.2026.116596,
  title = {Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA.},
  author = {Robert C and  Gérard E and  Lanoy E and  Quéreux G and  Bernard P and  Viguier M and  Grange F and  Meyer N and  Dinulescu M and  Legoupil D and  Neidhardt EM and  Saiag P and  Trabelsi S and  Célérier P and  Nardin C and  Maubec E and  Duval-Modeste AB and  Hainaut E and  Darras S and  Maillard H and  Guegan S and  Arnault JP and  Stoebner PE and  LE Corre Y and  Peuvrel L and  Bonniaud B and  Herrscher H and  Granel-Brocard F and  Vataire AL and  Tabellion A and  Lebbé C and  Mortier L.},
  year = {2026},
  journal = {Eur J Cancer},
  doi = {10.1016/j.ejca.2026.116596},
  url = {https://doi.org/10.1016/j.ejca.2026.116596}
}

RIS

TY  - JOUR
TI  - Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA.
AU  - Robert C
AU  -  Gérard E
AU  -  Lanoy E
AU  -  Quéreux G
AU  -  Bernard P
AU  -  Viguier M
AU  -  Grange F
AU  -  Meyer N
AU  -  Dinulescu M
AU  -  Legoupil D
AU  -  Neidhardt EM
AU  -  Saiag P
AU  -  Trabelsi S
AU  -  Célérier P
AU  -  Nardin C
AU  -  Maubec E
AU  -  Duval-Modeste AB
AU  -  Hainaut E
AU  -  Darras S
AU  -  Maillard H
AU  -  Guegan S
AU  -  Arnault JP
AU  -  Stoebner PE
AU  -  LE Corre Y
AU  -  Peuvrel L
AU  -  Bonniaud B
AU  -  Herrscher H
AU  -  Granel-Brocard F
AU  -  Vataire AL
AU  -  Tabellion A
AU  -  Lebbé C
AU  -  Mortier L.
PY  - 2026
JO  - Eur J Cancer
DO  - 10.1016/j.ejca.2026.116596
UR  - https://doi.org/10.1016/j.ejca.2026.116596
ER  -

APA

C, R., E, G., E, L., G, Q., P, B., M, V., F, G., N, M., M, D., D, L., EM, N., P, S., S, T., P, C., C, N., E, M., AB, D., E, H., S, D., H, M., S, G., JP, A., PE, S., Y, L. C., L, P., B, B., H, H., F, G., AL, V., A, T., C, L., & L., M. (2026). Cemiplimab versus historical systemic treatments for locally advanced or metastatic cutaneous squamous cell carcinomas: Results from the French study TOSCA.. Eur J Cancer. https://doi.org/10.1016/j.ejca.2026.116596

Source records

europe-pmc · retrieved 2026-09-27T04:25:02.317Z
hal · retrieved 2026-09-27T04:25:02.356Z